Top compounds associated with response to LYSMD1


Feature Type Standardized
Nominal ANOVA
mRNA AP-24534 GDSC1000 pan-cancer AAC -0.025 0.5
mRNA L-685458 CTRPv2 pan-cancer AAC 0.028 0.5
mRNA masitinib GDSC1000 pan-cancer AAC 0.024 0.5
mRNA SNX-2112:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.025 0.5
mRNA HG-5-88-01 GDSC1000 pan-cancer AAC 0.034 0.5
mRNA BRD-K20514654 CTRPv2 pan-cancer AAC 0.038 0.5
mRNA JQ-1:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.024 0.5
mRNA OSI-930 GDSC1000 pan-cancer AAC -0.025 0.5
mRNA PHA-665752 GDSC1000 pan-cancer AAC 0.038 0.5
mRNA SNX-2112 GDSC1000 pan-cancer AAC 0.022 0.5
Download CSV